We are live on
!
Find out more
PRNB
Principia Biopharma Inc. Common Stock
PRNB
PRNB
Delisted
PRNB was delisted on the 25th of September, 2020.
62 hedge funds and large institutions have $667M invested in Principia Biopharma Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 16 increasing their positions, 19 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
180% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 5
25% more capital invested
Capital invested by funds: $534M → $667M (+$133M)
17% more funds holding
Funds holding: 53 → 62 (+9)
16% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 19
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
62
Holders Change
+9
Holders Change %
+16.98%
% of All Funds
1.34%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.09%
New
14
Increased
16
Reduced
19
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$77.5M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$10.4M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.39M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$1.41M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.04M |
